NCT03525002View on ClinicalTrials.gov

Dopamine Action on Metabolism in Relation to Genotype

PHASE2RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 3, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2025

Conditions
Obesity
Interventions
DRUG

Bromocriptine

In each FTO genotype group participants will be randomly receive bromocriptine or placebo.

OTHER

Placebo

In each FTO genotype group participants will be randomly receive bromocriptine or placebo.

Trial Locations (3)

72076

RECRUITING

University of Tuebingen, Department of Internal Medicine IV, Tübingen

Unknown

RECRUITING

University Hospital Cologne, Cologne

RECRUITING

University Hospital Luebeck, Lübeck

All Listed Sponsors
collaborator

University Hospital of Cologne

OTHER

collaborator

University Hospital Lübeck

OTHER

lead

University Hospital Tuebingen

OTHER